AYTU - CIK 0001385818
The table below shows AYTU BIOPHARMA, INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $26.71M | $30.02M | $32.63M | $18.17M | $20.40M | $20.11M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $24.49M | $30.92M | $33.23M | $35.83M | $25.40M | $23.16M |
| Inventory | $7.46M | $8.66M | $10.10M | $11.06M | $11.09M | $11.74M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $67.33M |
| $76.24M |
| $81.11M |
| $72.51M |
| - |
| - |
| Property, plant & equipment | $407.00K | $484.00K | $500.00K | $546.00K | $516.00K | $692.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $111.69M | $122.00M | $124.99M | $124.20M | $116.23M | $115.83M |
| Accounts payable | $13.21M | $14.26M | $12.34M | $12.04M | $11.70M | $13.51M |
| Total current liabilities | $59.97M | $65.56M | $65.99M | $70.71M | $64.05M | $61.25M |
| Long-term debt | $9.55M | $10.00M | $10.45M | $9.54M | $9.98M | $10.43M |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | -$347.77M | -$342.15M | -$331.57M | -$313.72M | -$317.71M | -$318.50M |
| Total equity | $35.14M | $14.20M | $23.17M | $34.90M | $30.77M | $29.83M |